# HTEC (ROBO Global(R) Healthcare Technology and Innovation ETF)

ROBO Global · Thematic ETFs · data as of Sep 11, 2026

HTEC holds 59 stocks, and 68% of its weight is outside the S&P 500.

## Key facts

- HTEC, already in the S&P 500: 31.8%, as of Sep 11, 2026.
- HTEC, active share vs the S&P 500: 97.9%, as of Sep 11, 2026.
- HTEC, top ten holdings: 22.7%, as of Sep 11, 2026.
- HTEC, total return, 1 year: +32.0%, as of Sep 11, 2026.
- HTEC, net assets: $53m (SEC filing, whole fund, as filed for Apr 30, 2026).
- HTEC, expense ratio: 0.68% (485BPOS XBRL, Aug 27, 2026).

## HTEC over each window to Sep 11, 2026

| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
| --- | --- | --- | --- | --- |
| 3 months | +16.7% | +3.3% | +13.4 pts | +17.5 pts |
| 6 months | +25.9% | +16.0% | +9.8 pts | +5.2 pts |
| 1 year | +32.0% | +17.5% | +14.5 pts | +9.0 pts |
| 3 years | +51.8% | +77.9% | −26.1 pts | −43.3 pts |
| Since launch | +69.8% | +191.3% | −121.5 pts | −233.9 pts |

## Every published field

| Field | Value | Source |
| --- | --- | --- |
| Theme | Broad innovation and megatrends | ETFIQ, editorial |
| Launched | Jun 25, 2019 | ETFIQ |
| Already in the S&P 500, by weight | 31.8% | ETFIQ |
| Active share vs the S&P 500 | 97.9% | ETFIQ |
| Already in the Nasdaq-100, by weight | 9.1% | ETFIQ |
| Active share vs the Nasdaq-100 | 98.3% | ETFIQ |
| Top ten holdings weight | 22.7% | ETFIQ |
| Holdings | 59 | ETFIQ |
| Holdings as of | Apr 30, 2026 | SEC N-PORT |
| Top holdings | AxoGen, Inc. 3.2%, ARROWHEAD PHARMACEUTICALS, INC. 2.6%, Twist Bioscience Corp 2.3%, GLAUKOS CORPORATION 2.2%, NATERA, INC. 2.2%, TEMPUS AI, INC. 2.1%, NOVOCURE LIMITED 2.0%, ALNYLAM PHARMACEUTICALS, INC. 2.0%, GUARDANT HEALTH, INC. 2.0%, THERMO FISHER SCIENTIFIC INCORPORATED 2.0% | ETFIQ |
| Net assets | $53m | SEC filing, whole fund, as filed for Apr 30, 2026 |
| Below its all-time high | −20.7% | ETFIQ |
| Expense ratio | 0.68% | 485BPOS XBRL, Aug 27, 2026 |
| Fee for the part that differs from the S&P 500, active expense ratio | 0.69% | ETFIQ |
| Closest funds by holdings overlap | MDEV 30%, HELX 28%, EKG 24%, FMED 22%, WDNA 18% | ETFIQ |

## Questions

### How much of HTEC is in S&P 500 companies?

By its holdings filed for Apr 30, 2026, 32% of HTEC by weight is stocks the S&P 500 already holds. Its active share against the index is 98%, so that share is the part doing something different.

### What does HTEC hold?

59 positions as filed for Apr 30, 2026, with the top ten at 23% of the fund. The largest are AxoGen, Inc. at 3.2%, ARROWHEAD PHARMACEUTICALS, INC. at 2.6%, Twist Bioscience Corp at 2.3%.

### Has HTEC beaten the S&P 500?

Over the year to Sep 11, 2026 HTEC returned +32.0% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 14.5 points.

### What does HTEC cost?

The prospectus expense ratio is 0.68% a year. Because 98% of the fund differs from the S&P 500, the fee on that differing part works out at 0.69%.


## Cite this page

ETFIQ, HTEC, data as of Sep 11, 2026. https://etfiq.com/funds/htec
Free to use with attribution; the underlying files are at https://etfiq.com/data/.

HTML: https://etfiq.com/funds/htec  ·  JSON: https://etfiq.com/funds/htec.json